| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2013 |
| Trial ID | NCT03741127 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | P-BCMA-101 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101 |
| Year | 2018 |
| Country | Maryland |
| Company sponsor | Poseida Therapeutics, Inc. |
| Other ID(s) | P-BCMA-101-002 |
| Cohort 1 | |||||||
|
|||||||